BACKGROUND: The relationship between the prenatal environment, maternal-fetal interaction, and allergic disease in the offspring remains understudied. OBJECTIVE: We sought to determine whether gestational diabetes (GDM) modifies the risk of early childhood atopic manifestations, including atopic dermatitis and allergen sensitization. METHODS: This study includes 680 children from the Boston Birth Cohort. Mother-child dyads were recruited at birth and followed prospectively to a mean age of 3.2 +/- 2.3 years, with study visits aligned with the pediatric primary care schedule. The primary outcomes were physician-diagnosed atopic dermatitis on standardized medical record abstraction and allergen sensitization based on ImmunoCAP to 7 common foods and 5 common aeroallergens (specific IgE, >or=0.10 kUA/L; Phadia, Uppsala, Sweden). GDM was determined by means of standardized medical record review. Logistic regression analysis, stratified by term/preterm status, evaluated the association of GDM with atopic dermatitis and allergen sensitization, respectively, controlling for maternal prepregnancy body mass index, fetal growth, and pertinent covariates. RESULTS: Of the 680 children, 488 were term, and 192 were preterm (<37 weeks' gestation). Overall, 4.9% of the mothers had GDM. Among the 680 children, 34.4% had atopic dermatitis, and 51% had allergen sensitization. In term births GDM was significantly associated with atopic dermatitis (odds ratio [OR], 7.2; 95% CI, 1.5-34.5) and allergen sensitization (OR, 5.7; 95% CI, 1.2-28.0). Adjusting for fetal growth had little effect. The association with sensitization was driven primarily by food sensitization (OR, 8.3; 95% CI, 1.6-43.3). The above associations were not observed in preterm births. CONCLUSIONS: In term births GDM increased the risk of atopic dermatitis and early childhood allergen sensitization independently of maternal prepregnancy body mass index and fetal growth.
BACKGROUND: The relationship between the prenatal environment, maternal-fetal interaction, and allergic disease in the offspring remains understudied. OBJECTIVE: We sought to determine whether gestational diabetes (GDM) modifies the risk of early childhood atopic manifestations, including atopic dermatitis and allergen sensitization. METHODS: This study includes 680 children from the Boston Birth Cohort. Mother-child dyads were recruited at birth and followed prospectively to a mean age of 3.2 +/- 2.3 years, with study visits aligned with the pediatric primary care schedule. The primary outcomes were physician-diagnosed atopic dermatitis on standardized medical record abstraction and allergen sensitization based on ImmunoCAP to 7 common foods and 5 common aeroallergens (specific IgE, >or=0.10 kUA/L; Phadia, Uppsala, Sweden). GDM was determined by means of standardized medical record review. Logistic regression analysis, stratified by term/preterm status, evaluated the association of GDM with atopic dermatitis and allergen sensitization, respectively, controlling for maternal prepregnancy body mass index, fetal growth, and pertinent covariates. RESULTS: Of the 680 children, 488 were term, and 192 were preterm (<37 weeks' gestation). Overall, 4.9% of the mothers had GDM. Among the 680 children, 34.4% had atopic dermatitis, and 51% had allergen sensitization. In term births GDM was significantly associated with atopic dermatitis (odds ratio [OR], 7.2; 95% CI, 1.5-34.5) and allergen sensitization (OR, 5.7; 95% CI, 1.2-28.0). Adjusting for fetal growth had little effect. The association with sensitization was driven primarily by food sensitization (OR, 8.3; 95% CI, 1.6-43.3). The above associations were not observed in preterm births. CONCLUSIONS: In term births GDM increased the risk of atopic dermatitis and early childhood allergen sensitization independently of maternal prepregnancy body mass index and fetal growth.
Authors: Lin Wang; Xiaobin Wang; Nan Laird; Barry Zuckerman; Philip Stubblefield; Xin Xu Journal: Am J Hum Genet Date: 2006-03-10 Impact factor: 11.025
Authors: P Leadbitter; N Pearce; S Cheng; M R Sears; M D Holdaway; E M Flannery; G P Herbison; R Beasley Journal: Thorax Date: 1999-10 Impact factor: 9.139
Authors: Franca Rusconi; Claudia Galassi; Francesco Forastiere; Marta Bellasio; Manuela De Sario; Giovannino Ciccone; Luigia Brunetti; Elisabetta Chellini; Giuseppe Corbo; Stefania La Grutta; Enrico Lombardi; Silvano Piffer; Fiorella Talassi; Annibale Biggeri; Neil Pearce Journal: Am J Respir Crit Care Med Date: 2006-09-22 Impact factor: 21.405
Authors: D J Purvis; J M D Thompson; P M Clark; E Robinson; P N Black; C J Wild; E A Mitchell Journal: Br J Dermatol Date: 2005-04 Impact factor: 9.302
Authors: K C Lewandowski; N Stojanovic; M Press; S M Tuck; K Szosland; M Bienkiewicz; M Vatish; A Lewinski; G M Prelevic; H S Randeva Journal: Diabetologia Date: 2007-03-02 Impact factor: 10.122
Authors: X Liu; G Wang; X Hong; D Wang; H-J Tsai; S Zhang; L Arguelles; R Kumar; H Wang; R Liu; Y Zhou; C Pearson; K Ortiz; R Schleimer; P G Holt; J Pongracic; H E Price; C Langman; X Wang Journal: Allergy Date: 2011-08-05 Impact factor: 13.146
Authors: Jennifer T Smilowitz; Carlito B Lebrilla; David A Mills; J Bruce German; Samara L Freeman Journal: Annu Rev Nutr Date: 2014-05-15 Impact factor: 11.848
Authors: Shreyas V Kumbhare; Dhrati V V Patangia; Ravindra H Patil; Yogesh S Shouche; Nitinkumar P Patil Journal: J Biosci Date: 2019-06 Impact factor: 1.826
Authors: Emily C McGowan; Xiumei Hong; Jacob Selhub; Ligi Paul; Robert A Wood; Elizabeth C Matsui; Corinne A Keet; Xiaobin Wang Journal: J Allergy Clin Immunol Pract Date: 2019-06-25
Authors: Jennifer T Smilowitz; Sarah M Totten; Jincui Huang; Dmitry Grapov; Holiday A Durham; Carol J Lammi-Keefe; Carlito Lebrilla; J Bruce German Journal: J Nutr Date: 2013-09-18 Impact factor: 4.798
Authors: Guoying Wang; Sara Divall; Sally Radovick; David Paige; Yi Ning; Zhu Chen; Yuelong Ji; Xiumei Hong; Sheila O Walker; Deanna Caruso; Colleen Pearson; Mei-Cheng Wang; Barry Zuckerman; Tina L Cheng; Xiaobin Wang Journal: JAMA Date: 2014-02-12 Impact factor: 56.272